Logo Image Logo Image
Visit us at
TCT 2019
The Future will be driven by RESEARCH, armed with TECHNOLOGY and boosted with INNOVATION. We invite you to "Partner the Future" with our latest innovations.
We look forward to seeing you in TCT, 26th to 28th September '19
MyVal-1 Study
Myval THVTM is a Next Generation TAVR technology amalgamating virtues of Novel Valve Design elements resulting in Accurate Positioning and Orthotopic Valve Deployment. Myval THVTM is designed keeping Precision at its Heart, ensuring predictable clinical safety and efficacy outcomes.
CE Annoucement
Know more at
MeRes100TM - Meril's Bioresorbable vascular scaffold system receives CE Approval
MeRes-1 and MeRes-1 Extend Study
MeRes100TM BRS is the Next Generation Bioresorbable technology with low strut thickness of only 100 microns; which leads to lower crossing profile for ease of delivery thereby minimising vascular injury & ensuring early endothelialisation.
To know more about MeRes100TM Logo Image
We invite you to our lunch symposium on 'Novel Technologies from Meril's Armamentarium'. Know more about Clinical Evidence of Key Meril's Innovations such as MyvalTM THV and MeRes100TM at Presentation Theatre 3, Moscone South
28th September from 01:00 pm onwards
View Symposium Agenda
We invite you to our Booth #943 to learn more about our innovations. Have one-on-one focused sessions in our meeting rooms and have hands-on and VR sessions on Meril's TAVR system - MyvalTM THV.
MeRes-1 and MeRes-1 Extend Study
Late Breaking
Trial Presentations
Logo Image
Know more
Meril at TCT
Meril Life Sciences
MyvalTM & MeRes100TM is a registered trademark of Meril Lifesciences Private Limited.
The products are intended for use by or under the direction of a trained healthcare practitioner only. Prior to use, refer the instructions for use/IFU. Illustrations are artist's representations only and should not be considered as engineering drawings or photographs. Data, Photos and videos on file at Meril Life Sciences Pvt. Ltd.